Learn more about Monash Health’s Haematology team.
Dr Zoe Loh
Dr Zoe Loh is a clinical and laboratory haematologist at Monash Health and Austin Health, and a PhD candidate at the Olivia Newton-John Cancer Research Institute (ONJCRI). She has an interest in malignant haematology, in particular lymphoma.
Her PhD is funded by a National Health and Medical Research Council (NHMRC) scholarship and focuses on novel therapies and biomarkers for Mantle Cell Lymphoma.
Recent publications
Loh Z, Ashby M, Rahman M, Wong EY, Ong DM, Morgan S, Chua CC. High burden and poor outcomes of myelodysplastic neoplasms (MDS) in the real-world: a 10-year audit of three Australian hospitals. Leukemia & Lymphoma 2025
Douglas G, Loh Z, Shum ESY, Lee ST, Waters N, Hamilton G, Chong G, Murphy AC, Hawkes EA. PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma. Blood Advances 2025
Loh Z, Ashby M, Iland H, Grigg A. Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia. British Journal of Haematology 2024
Loh Z, Salvaris R, Chong G, Churilov L, Manos K, Barraclough A, Hawkes EA. Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years. British Journal of Haematology 2021
Loh Z, Hawkes EA, Chionh F, Azad A, Chong G. Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic. Clinical Lymphoma Myeloma Leukemia 2021